Trial Profile
Feasibility study of neo-adjuvant chemotherapy using paclitaxel and carboplatin followed by radical radiotherapy with CHARTWEL [radiotherapy regimen] in non-small cell lung cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Aug 2005
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 02 Aug 2005 New trial record.